Physician
Fredonia Regional Hospital
Fredonia Regional Hospital was paid $662K by Medicaid between Jan 2018 and Oct 2024, across 53 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 70% of everything it billed.
33Billing provider infoFREDONIA REGIONAL HOSPITAL
FREDONIA, KS 66736
FREDONIA, KS 66736
33aNPI1285634006assigned 07/22/2005
33bProvider typeEmergency Medicine Physician
28Total paid$662K
24GClaims24,506
24DCodes billed53
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Emergency Medicine Physician providers in Kansas
Rank by total paid#14 of 83
Median peer was paid$37K
This provider vs. median18×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,390 | $153K | |
| 2019 | 3,141 | $41K | |
| 2020 | 3,703 | $70K | |
| 2021 | 3,920 | $244K | |
| 2022 | 2,588 | $136K | |
| 2023 | 3,570 | $9K | |
| 2024incomplete | 1,194 | $9K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 70% | 1,081 | 980 | $461K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 4.2% | 463 | 403 | $28K |
| 80053 | Comprehensive metabolic panel | 3.9% | 3,676 | 2,936 | $26K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3.4% | 395 | 368 | $23K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3.4% | 394 | 368 | $23K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3.0% | 1,487 | 1,321 | $20K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 3,805 | 3,021 | $11K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.5% | 400 | 279 | $10K |
| 87070 | 1.4% | 985 | 910 | $9K | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 1.3% | 163 | 117 | $9K |
| 87486 | <1% | 350 | 324 | $5K | |
| 87581 | <1% | 350 | 324 | $5K |
41 more codes
| 83735 | <1% | 1,355 | $5K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 48 | $4K |
| 99283 | Emergency room visit (moderate) | <1% | 115 | $3K |
| 84100 | <1% | 1,316 | $3K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 728 | $3K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 154 | $2K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 12 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 193 | $1K |
| 87653 | <1% | 28 | $1K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 74 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 55 | $1K |
| 87077 | <1% | 108 | $980.77 | |
| 80061 | Lipid panel | <1% | 108 | $885.99 |
| 87186 | <1% | 69 | $774.63 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 110 | $721.08 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 24 | $480.91 |
| 81001 | <1% | 122 | $414.03 | |
| 87081 | <1% | 45 | $394.20 | |
| 0012A | <1% | 53 | $369.96 | |
| 85027 | <1% | 51 | $339.63 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 40 | $271.21 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 20 | $268.85 |
| 0011A | <1% | 56 | $257.42 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 24 | $201.73 |
| 87040 | <1% | 12 | $176.86 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 28 | $149.40 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 21 | $115.35 |
| 84439 | <1% | 14 | $110.04 | |
| 87205 | <1% | 27 | $107.90 | |
| 85007 | <1% | 51 | $79.69 | |
| 85651 | <1% | 19 | $77.64 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,414 | $71.92 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 181 | $51.96 |
| J3490 | Unclassified drugs | <1% | 52 | $34.37 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 24 | $15.51 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 32 | $3.48 |
| 99213 | Doctor's office visit, returning patient (routine) | 0% | 60 | $0.00 |
| A0427 | Emergency ambulance ride, advanced life support | 0% | 13 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 26 | $0.00 |
| A0425 | Ground mileage, per statute mile | 0% | 27 | $0.00 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 48 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROW, TRACY (BUSINESS OFFICE MANAGER)
| Provider | Location | Paid |
|---|---|---|
| Fredonia Regional Hospital | Fredonia, KS | $46K |
| Fredonia Regional Hospital | Fredonia, KS | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.